Ignite Creation Date:
2024-05-05 @ 11:19 AM
Last Modification Date:
2024-10-26 @ 9:01 AM
Study NCT ID:
NCT00000300
Status:
COMPLETED
Last Update Posted:
2017-11-01
First Post:
1999-09-20
Brief Title:
Feasibility Study of Take-Home LAAM Medication - 3
Sponsor:
University of California Los Angeles
Organization:
University of California Los Angeles
Study Overview
Official Title:
Feasibility Study of Take-Home LAAM Medication
Status:
COMPLETED
Status Verified Date:
1995-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to test therapeutic benefits of take-home LAAM 1 Do subjects with take-home LAAM availability show increased clinical responsibility over subjects without 2 Do subjects with take-home LAAM attempt diversion when random recall and other diversion safeguards are used 3 Does treatment response correlate with background or drug use variables at intake discharge or during treatment
Detailed Description:
1-Year study participant will be randomly assigned to one of two groups One will have the opportunity to earn take-home doses by turning in a designated number of clean urines Two will not have the opportunity to earn take-home doses Clinic visits three times per week Urine sample given at each visit
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| P50-09260-3 | US NIH GrantContract | None | httpsreporternihgovquickSearchP50DA009260 |
| P50DA009260 | NIH | None | None |